Vogenx, Inc. (VOGX)
18.72
+0.49
(+2.69%)
USD |
NASDAQ |
Nov 06, 10:20
Vogenx Enterprise Value : 271.48M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 271.48M |
| November 04, 2026 | 293.77M |
| November 03, 2026 | 305.65M |
| November 02, 2026 | 308.77M |
| October 30, 2026 | 301.49M |
| October 29, 2026 | 296.59M |
| October 28, 2026 | 281.73M |
| October 27, 2026 | 285.30M |
| October 26, 2026 | 258.26M |
| October 23, 2026 | 259.90M |
| October 22, 2026 | 284.11M |
| October 21, 2026 | 303.57M |
| October 20, 2026 | 279.21M |
| October 19, 2026 | 237.17M |
| October 16, 2026 | 216.52M |
| October 15, 2026 | 239.10M |
| October 14, 2026 | 239.84M |
| October 13, 2026 | 249.65M |
| October 12, 2026 | 255.29M |
| October 09, 2026 | 261.53M |
| October 08, 2026 | 260.49M |
| October 07, 2026 | 240.73M |
| October 06, 2026 | 244.15M |
| October 05, 2026 | 255.44M |
| October 02, 2026 | 271.48M |
| Date | Value |
|---|---|
| October 01, 2026 | 298.67M |
| September 30, 2026 | 339.22M |
| September 29, 2026 | 361.88M |
| September 28, 2026 | 327.49M |
| September 25, 2026 | 338.33M |
| September 24, 2026 | 360.17M |
| September 23, 2026 | 399.68M |
| September 22, 2026 | 395.38M |
| September 21, 2026 | 438.90M |
| September 18, 2026 | 483.47M |
| September 17, 2026 | 507.68M |
| September 16, 2026 | 496.69M |
| September 15, 2026 | 479.16M |
| September 14, 2026 | 482.28M |
| September 11, 2026 | 486.59M |
| September 10, 2026 | 444.25M |
| September 09, 2026 | 443.36M |
| September 08, 2026 | 476.04M |
| September 04, 2026 | 472.03M |
| September 03, 2026 | 478.27M |
| September 02, 2026 | 477.52M |
| September 01, 2026 | 492.82M |
| August 31, 2026 | 505.75M |
| August 28, 2026 | 505.15M |
| August 27, 2026 | 500.25M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IGC Pharma, Inc. | 20.08M |
| Cocrystal Pharma, Inc. | 12.89M |
| CNBX Pharmaceuticals, Inc. | 1.305M |
| Arvinas, Inc. | -121.78M |
| Fulcrum Therapeutics, Inc. | -32.83M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.3844M |
| Total Expenses (Quarterly) | 0.3844M |
| EPS Diluted (Quarterly) | -0.0259 |
| Earnings Yield | -0.54% |
| Normalized Earnings Yield | -0.5395 |